Galux Positions AI Antibody Platform For Global Stage
Korean biotech Galux tells Scrip how it is gaining international credibility through global research partnerships, underpinned by its proprietary AI-powered antibody design platform.
Scrip - July 15, 2026

Whoop And Kinomatic Partner On Joint Replacement Recovery Pilot Targeting Opioid Reduction
Kinomatic and Whoop have launched a 12-week pilot to test whether continuous wearable monitoring can improve post-op outcomes and reduce opioid use in knee and hip replacement patients across three California clinics.
Medtech Insight - July 14, 2026

US FDA Promotes Deputy To Acting Chief Information Officer
New Acting CIO Sanjay Kumar Sahoo is an agency veteran who helped consolidate the centers’ adverse event reporting systems.
Medtech Insight - July 14, 2026

Claria Medical Wins De Novo Clearance Via STeP Pathway For Novel Contained Hysterectomy System
The US FDA has cleared Claria Medical's Claria System, a transvaginal hysterectomy device, via the STeP accelerated pathway. The company says the integrated device can remove a large uterus in an average of four minutes; full clinical trial data are expected later this year.
Medtech Insight - July 14, 2026

FDA Flags Medtronic Harmony Catheter Recall As Class I Over Tip Detachment
The FDA has designated Medtronic's recall of the Harmony Delivery Catheter System as Class I after reports the catheter's distal tip can detach during implantation. The action spares the Harmony pulmonary valve itself.
Medtech Insight - July 14, 2026

A Pump Under Pressure: Fresenius Kabi’s Ivenix Keeps FDA Busy
A string of Class I recalls in two years, including a battery defect that appears to persist through its own fix, is turning Fresenius Kabi's Ivenix pump from a reliability-first disruptor into a mounting quality liability.
Medtech Insight - July 14, 2026

Alzheimer’s Blood Tests Equally Accurate In Primary, Secondary Care: Study
New data revealed at AAIC shows blood biomarkers proving their potential to diagnose Alzheimer’s in the sought-after primary care market – and may even have higher accuracy than other tests.
Medtech Insight - July 14, 2026

Internal Medicine Specialists Group Suggests Tracking Supplement Use Like Prescription Drugs
American College of Physicians study notes that “only one quarter” of the nearly 60% of US consumers older than 20 who report using supplements in the past 30 days “consume supplements that have been recommended by a health care professional.”
HBW Insight - July 14, 2026

Walmart Agrees To Police Mercury Content In Skin Lighteners Under NGO Settlement
Walmart Inc. agrees to monitor and remove skin lightening products with mercury above trace levels under a settlement with the Mercury Policy Project, in addition to paying more than $1m in penalties.
HBW Insight - July 14, 2026

Sweden Bridges The Gap Between Prescription And OTC With New Category
Sweden will have a pharmacist-only medicines category from the start of 2027, opening up a new pathway for Rx-to-OTC reclassifications. Industry association Lif tells HBW Insight the reform could boost self-care access and draw investment, providing switch application rules are kept workable.
HBW Insight - July 14, 2026

Over The Counter: The Dos And Don’ts Of Health Literacy, With Self-Care Forum’s Trevor Gore
HBW Insight speaks to Self-Care Forum trustee and behavioural scientist Trevor Gore about why treating health literacy as a readability exercise misses the real task of changing what people do about their health.
HBW Insight - July 14, 2026

Federal Appeals Court Clears Plaintiffs’ Experts To Testify In OTC Acetaminophen Class Action
Circuit court decision returns to Southern New York District class action litigation alleging prenatal use of acetaminophen linked to autism and/or attention-deficit hyperactivity disorder in children, allowing testimony from three of six plaintiffs’ expert
HBW Insight - July 14, 2026

Consumers Will Push Back Against AI Reshape Of Beauty Marketing – Mintel
Consumer backlash against AI, demand for multisensory product experiences, and the rise of metabolic health will define the beauty industry through the end of the decade, says Mintel.
HBW Insight - July 14, 2026

Apotex Challenges Sandoz’s Infuvite With US Launch Of Generic Multivitamin Injections
Apotex enters the parenteral nutrition market by launching a generic version of the multivitamin injection Infuvite, boosted by a competitive generic therapy designation exclusivity.
Generics Bulletin - July 14, 2026

Generic And Biosimilar Industry: Let Us Into US FDA National Priority Voucher Program
The generic drug lobbying group argued generics and biosimilars satisfy four of the FDA's five National Priority Voucher priorities.
Generics Bulletin - July 14, 2026

Natco Pharma Raises The Stakes Again, Taking 49% Share In Adcock Ingram
Indian multinational pharma company Natco Pharma has raised its stake in Adcock Ingram to 49%, in a $110m acquisition.
Generics Bulletin - July 14, 2026

What Industry Can Learn From The CAR-T Commercialization Playbook
Kite Pharmaceuticals' CAR-T therapy Yescarta met its internal launch forecast yet is widely perceived as a commercial underperformer. Two industry experts who lived through the launch explain what the gap between checkers-level and chess-level commercial strategy still means for the industry today.
In Vivo - July 14, 2026

When A Royalty Is Not Bankruptcy-Proof: Structuring Lessons from Mallinckrodt
Mallinckrodt's 2020 bankruptcy proved a synthetic royalty is only as safe as its structure. Absent a security interest or ownership stake, investors are just unsecured creditors facing discharge.
In Vivo - July 14, 2026